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DISEASE MANAGEMENT
I.

OVERVIEW

A.

Definition
Disease management is a comprehensive, integrateaapprnach
to care and reimbursement based on the natural course of a
disease, with treatment designed to address an illness with
4
maximum effectiveness and efficiency.

B.

General
In the March, 1992 issue of the New England Journal of
Medicine article by K. Weiss, et al., the costs of asthma,
estimated to be $6 billion annually in the U.S., include drug
therapy, hospitalization costs, visits with physicians, and
detailed diagnostic tests. Other researchers have noted that
asthma costs are heavily concentrated in a small portion of the
affected population: 5% of the asthmatics account for 70% of
1
the costs associated with the disease.
The Weiss study pointed out that 43 % of the total system
costs are associated with the disease on patients with out-ofcontrol cases: emergency room treatments, hospitalization, and
death. An economic analysis in a sample population indicates
that by managing the condition effectively through early
intervention and prevention, a system wide savings of 25 %
1
could be realized.
The techniques that could be used to achieve these savings
include patient education programs to ensure the proper use of
steroids and physician education targeted at early identification
and appropriate specialist referral. The program would satisfy
both the clinical goal of long term control of the condition and
4
the economic goal of cost containment.
A number of healthcare delivery companies have realized that if
costs are truly to be brought under control and better quality
care is to be provided, a new paradigm is needed, one focused
on market based system management oriented around
particular diseases. Each disease has a distinctive pattern of
cost elements, a different and varying pattern of cost
occurrence during its course, and a unique range of available

therapies and interventions. Accordingly, the building blocks
2
for analyses and system design should be specific diseases.
At the 1994 annual meeting of the National Wholesale
Druggists' Association (NWDA), Thomas A. Moore of Procter &
Gamble said that any new health care system will be measured
in terms of the perceived value it gives to the eonsumer.
Pharmacists have a major opportunity to serve the consumer by
providing cognitive services. After a slow start, pharmacists
are enlarging their role in that area through limited patient
counseling and drug utilization review. Payers are going to
start demanding cognitive services and are probably going to
be willing to pay for them. Moore told NWDA wholesaler and
manufacturer members that there are at least 2 key areas in
which the drug industry can profit: prescription drugs and
over-the-counter (OTC) drugs. More prescription drugs could
mean less net cost to the system if enough cognitive services
are delivered to make the products effective, and costconscious managed care organizations would rather use
consumer-purchased OTCs as a first line of therapy if
10
possible.
C.

CLINICAL QUALITY
Clinical quality has become, at least nominally, the basis upon
which HMOs, other managed care plans, and employers are
seeking to differentiate providers and to make purchasing
decisions. For these criteria to be credible, it is important to
establish the medical community's ability to measure and
document quality objectively. Although significant strides in
this direction have been made, we believe that the medical
industry is still in the early stages of compiling and providing
reliable information on clinical quality.
Clinical quality consists of four components:
1.
2.
3.

4.

Appropriateness of care, including compliance with
practice guidelines
Technical effectiveness, including measurable clinical
outcomes.
Functional outcomes, including patient satisfaction and
whether the treatment accomplished its stated
objectives.
Efficiency (i.e., whether the appropriate clinical resources
were used to achieve the desired result).
2

Gathering and formatting information to be used in establishing
the criteria for evaluating clinical quality (and for its continuing
measurement and dissemination) is a major undertaking that is
becoming increasingly critical to the clinical management
processes of integrated delivery systems.

II.

INDUSTRY TRENDS

A.

Industry Leaders
Some of the leading managed care companies in the U.S. are
beginning to put a disease oriented approach in place. Some of
the leaders are the Group Health Cooperative of Puget Sound
with its Diabetes Roadmap effort in- conjunction with Eli Lilly
and Boehringer Mannheim; Harvard Community Health Plan,
with its algorithm approach to disease management; and Deere
and Co., which is working with the Mayo Clinic on a disease4
management system for its employees.

B.

Pharmaceutical Industry RelationshiQ;°
As noted in the Group Health Diabetes effort, the
pharmaceutical industry has expanded its role into outcomes
research through the rapid acquisitions recently of pharmacy
benefit management companies (PBMs) whose services include
claims processing and complete drug benefit administration.
Reasons for the acquisitions include heavy price pressure from
managed care organizations (MCOs) and Pharmacy Benefit
Management organizations (PBMs), restrictive formularies of
MCOs and PBMs, and access to the PBMs extensive pharmacy
claims data which can be utilized for outcomes research to
justify formulary decisions.
"Closely tied with the focus on outcomes research is perhaps
the most revolutionary concept emerging from vertical
pharmaceutical
integration:
drug
companies
positioning
themselves as disease management entities. The goal is to
change the image of drug companies from sellers of pills to
providers of patient care strategies. Because of the emphasis
on correct and consistent drug usage, disease management
initiatives predominantly target chronic conditions that have
notoriously high non-compliance rates, such as diabetes,
asthma, and hypertension. The theory behind drug company
involvement in patient care strategies is that the pharmaceutical
company understands the physiologic mechanisms through
3

which the disease operates and can take the talent, the
knowledge, and the interaction between the scientist and the
3
clinician and apply it to the management of the disease itself. "
As an outgrowth of this movement, Pfizer and Value Health are
collaborating on a joint venture in disease management. In
addition, Merck, Smith Kline-Beecham, and Eli Lilly are ' all
developing pharmaceutical care and disease management
programs through their newly purchased PBM divisions.

C.

Cleveland Clinic

Lessons learned from original case management efforts proved
that multi-disciplinary groups could establish coordinated care
tracks based on clinical judgments and statistical data. The
CCTs serve as standards of care by identifying the specific
sequence and timing of multiple interventions. Much of the
early efforts concentrated on the when" and how" of a
particular intervention, and utilization review focused on
reduction of length of stay and on system processes to ensure
that the when" and how" occurred as defined. A criticism of
this approach is that the appropriateness of the intervention
may be overlooked. Therefore, a major focus of current work
is to ensure that the most effective and efficient interventions
are done. This has led to practice changes regarding drug and
other therapies. Examples follow:
11

11

11
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1.

Intravenous human immune globulin has been removed
from the autologous bone marrow protocol resulting in a
$2,500 per patient cost savings.
Additionally, oral
aminocaproic has been introduced as a homegoing
medication in the thrombocytopenic autologous bone
marrow transplant population.

2.

Reassessment of proper time for nasogastric (NG) tube
removal in the colorectal population has allowed 80
percent of the population to have their NG tube removed
one day sooner than established protocol. This allows
for earlier nutritional decisions and supports patient
recovery.

3.

Radical prostatectomy patients who develop urine leaks
(approximately 10 percent of the population) are
discharged to home with drains and instructions, or

4

referred to home care services. These activities allow for
better utilization of resources.
Following the principles of vertical integration (mainly the
coordination of service lines with the different stages of
production) the nursing case management process has
broadened its definition of episode of illness from tt:le hospital
component to include all CCF care interactions.
Nurses
contribute to patient outcomes in every aspect of clinical care.
Nursing is a partner in maintaining and improving the Cleveland
Clinic Foundation's efficiency.
Efficiency, as a vertical
integration motivator, focuses on production costs, contractual
costs, and information economics (Arndt & Bigelow, 1992).
Alternate site care coordination is an example of efficiency.
This service coordinates care for subacute skilled and home
skilled services, home infusion therapy, home hospice care, and
home respiratory care. The subacute care program, directed by
nurses, offers short-term 24 hour skilled nursing care to
patients who do not need the acute care resources of the
hospital. Skilled nursing care facilities (SNF) with specialized
subacute units are contracted to provide care. Selected SNFs
,meet staffing requirements, possess the needed clinical
expertise and agree to follow the CCF established medical
programs and procedures for care.
This program therefore
provides for full continuity of care and streamlines the
transition process of patients to appropriate post- discharge
care. The economics translate into tighter links between CCF
and SNFs with the transfer and use of information between
different levels of care. This program is one example of what
Conrad & Bigelow ( 1990) identify as finding synergy's between
different levels of care processes.
The discharge planning function of the case manager, coupled
with the alternate site care coordination ensures care
coordination post-discharge.
Expansion of the practice and
principles of nursing case management into the outpatient
clinics is also presently evolving. By its very structure, the CCF
has linkages between inpatient and outpatient facilities, thereby
eliminating many production and transaction costs.
The
introduction of nursing case management in the outpatient
setting is specific to those patients who require a clinic visit
beyond routine return appointments following hospitalization.
This unplanned visit, viewed as a variance, is investigated by
the case manager to determine cause. If provider issues are
the cause (e.g. inadequate patient education regarding
5

medications), a continuous quality improvement process will be
initiated to identify factors contributing to the variance. Finally,
aggregate data analysis allows for CCT revisions.
Additionally, the outpatient clinic nurse will assess whether
attainment of the discharge criteria have been sustained after
the patient is discharged. These data assist in examining ·the
episode of care for a disease condition rather than for analysis
of a specific setting. Coordinated care tracks, which represent
the trajectory of an illness or disease condition, and then be
developed. These CCTs can assist in preventing the underuse
and overuse of resources.
Additionally, the data serve as
measures of previous hospitalization and its effectiveness.
111.

MEASURING QUALITY OF CARE IN PHYSICIANS OFFICES.
A.

6

General

As the utilization of medical services has increased, the cost of
medical services has also increased. As attempts are made to
reduce costs, the concern about quality of care increases.

B.

Utilization of Medical Services

The appropriate utilization of medical services is controversial
because conclusive information on prevention and treatment of
disease does not exist. Therefore, much of what is done in
medicine is based on incomplete information. For example, the
treatment of a sore throat, may generally involve culture of the
throat and antibiotics. Specifically when to culture and which
antibiotic to use will vary from physician to physician and,
frequently, from patient to patient.
Also, we know that patients may have different concerns
regarding their health than do physicians or insurers of health
care. For example, diminishing the symptoms of a sore throat
is usually of primary importance to patients. For physicians,
preventing the occurrence of rheumatic fever may be the top
priority. Finally, for insurers of health care, limiting the cost of
medical services for minor conditions such as sore throat may
be of primary importance. Our current, knowledge of health
care presents us with incomplete data on which to determine
appropriate utilization of medical services, and therefore,
evaluate the appropriateness of medical care.

6

In light of these differences, there are two immediate objectives
of quality assurance. The first is to demonstrate and document
good quality be providing findings and explaining methods to
those who use and to those who pay for medical services. The
second objective is to provide for continuous improvement in
quality by those who provide medical services.
A model is needed for physicians offices that defines quality of
care, recognizes the lack of complete information on the
prevention and treatment of disease, accommodates the
controversy on utilization of medical services, and provides
ongoing cost savings. Such a model does exist. In the health
care industry physicians provide quality medical care when they
meet the needs of their customers, their patients. These needs
are universal and easily defined; they are what each of us
desire for ourselves and those we love: competence,
commitment, convenience, courtesy, and compassion.
To
date, systems that have attempted to measure quality of
medical care have focused on professional competence only.
The other four needs have been assumed to be present and
have not been measured directly. To be effective, a quality
assurance system should be concerned with all five patient
needs.
There are three components to examine when assessing
performance structure, process, and outcome. To examine the
structure under which good medical care is provided, an
evaluation of the training, credentials, experience, equipment,
and facilities required to provide medical care must be made.
These parameters are measured by reviewing medical staff
files, m medial school and specialty certifications, and
performing site visits and inspections
The second component, the process of providing medical care,
can be evaluated by looking at the decision-making, testing,
procedures, and treatments that comprise medical care. These
parameters are measured from billing data, medical chart
review, patient questionnaires, simulated patient encounters,
and patient interviews.
Finally, the outcome of the medical care provided must be
examined.
Many outcomes are relevant to quality
measurement such as the incidence of postoperative
infections and anesthetic complications. Many other outcome
measures have limitations in evaluating the performance of
7

individual physicians. For example, many bad outcomes are
expected to occur infrequently, after long delays, or not at all
despite poor care. Thus, evaluating whether the process of
medical care that has been accepted as essential to the
prevention of a specific outcome has been followed is, in many
cases, a better measure of quality than is the nonoccurrence of
the outcome.
C.

Use of Standards

Consideration should be given to selecting standards that meet
the test of acceptability, specificity, and measurability.
Acceptability is achieved by selecting standards from those that
are published by recognized authorities and accepted by most
physicians. Organizations such as the United States Preventive
Services Task Force, the Centers for Disease Control, the
National Committee for Quality Assurance, and the Joint
Commission of Accreditation of Healthcare Organizations have
published recommendations on medical care.
Controversial
standards should be avoided and individual organizations or
groups should not attempt to develop their own standards.
Specificity is achieved by selecting explicit standards. Explicit
standards have specific instructions that lessen the need for
judgment by individuals and, therefore, can avoid bias. For
example, uses consultants appropriately" appears to be a
good
question
and
is
a commonly
used
standard.
(Unfortunately, any time the word appropriate in a standard
an expert" is required to determine appropriateness." An
expert
tends to assess performance from the perspective
of the impact of the standard on the patient population as a
whole rather than from the perspective of the consequences for
an individual patient. Practicing physicians judiciously reverse
these priorities.
In addition, because evaluating standards
requires medical judgment, assessments that require experts"
are expensive, cannot be done cost-effectively, and produce
inconsistent findings.
11
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Measurability is achieved by selecting standards that can be
accurately measured in a cost-effective way.
Are office hours
convenient?" is an important question to ask when evaluating
the accessibility of facilities and services. This can accurately
and inexpensively be answered by means of a patient
questionnaire.
11
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D.

Corrective Actions To Improve Quality of Care.

Corrective actions should be aimed at making it easier for
physicians to comply with the selected standards. Problems in
quality are not generally caused by incompetence or poor
intentions on the part of physicians. Most physicians are highly
motivated. Performance cannot be changed through- attempts
to increase motivation. Instead, evaluation of quality must be
translated into pragmatic tools to influence directly the delivery
of care.
The quality of care is determined by individual physicians
making decisions on individual patients.
To impact quality,
information must be provided to affect decisions at this level.
The quality assurance information developed from assessing
performance should be reviewed with individual physicians.
Areas of strength and areas of weakness should be identified.
Incentives for improvement and the means to accomplish it
should be discussed and agreed upon.
If problems are common to most physicians within a group, a
system change can improve results. For example, it is unusual
to find an organized method of recording adult immunizations
when auditing medical records of primary care physicians. If a
group has low scores with regard to adult immunizations, a
simple form for recording immunization of adults provides a
convenient reminder to physicians of this standard.
If problems are common to only a few physicians, awareness,
education, or other individual consequences may be required.
Often the knowledge that performance is variant from that of
others causes change in behavior. It is a mistake to believe
that there is always a "right" answer; as medical care changes,
the "right" answer also changes.
Over time, accepted
practices shown to be ineffective are replaced by newer ones
believed to be effective.
The corrective action must be supportive of the individual
physician. Threatening information becomes information to be
ignored or defended against.
More importantly, supportive
information becomes information that can modify decisions and
improve medical care. Low scores do not necessarily indicate
bead physicians; they indicate problems that food physicians
will correct.

9

IV.

PRACTICE PARAMETERS
A.

7

General
Practice parameters are strategies for patient management,
developed to assist physicians in clinical decision making.
Practice parameters include guidelines, standards, -and other
patient management strategies.

B.

History
As the demonstrated usefulness of these patient management
strategies has grown, interest in the development of practice
parameters has grown.
In the 1930's, only one physician
organization was developing practice parameters.
By 1980,
eight physician organizations were actively engaged in their
development. As of 1991, at least 32 physician organizations
have developed practice parameters, and many other physician
organizations are planning to do so.
In total, over 1. 100
practice parameters have been developed by physician
organizations and others.
In addition, at the beginning of
1991, over 1 50 practice parameters were under development.
The medical profession has been the primary force in the
development
of
practice
parameters,
although
other
organizations, such as the federal government, have recently
initiated activities in this area.

C.

Application of Practice Parameters
The use of practice parameters has been helpful in several
areas such as:
1.
2.
3.
4.
5.
6.

D.

Appropriateness of Care
Risk Management
Credentialling
Quality Assurance
Utilization Review
Payment Coverage Decisions

Medical Review System

11

In response to calls for value in health care, managed care
organizations are seeking ways to manage treatment on the
front end. The transition from retrospective utilization review

10

to prospective decision making using practice guidelines is
typified by Blue Plus experience reviewing appropriateness of
medical procedures. In its program, specialists recommending
surgery must run their patient's clinical indications through a
Medical Review System, which uses an algorithm to review the
criteria. If the computer rejects the information, it is referred to
a physician who conducts peer review. If the procedure later
fails at an appeal level, Blue Plus will not pay for it. According
to Blue Plus' Mark Banks, the program has been successful in
reducing the number of inappropriate procedures. Instead of
reviewing appropriateness, United Healthcare Corporation, of
Minneapolis, is targeting disease prevention.
In developing
practice guidelines, Winston-Salem Health Care Plan Inc. uses
practice parameters written by the medical specialties as a
starting point.

E.

Blue Cross and Blue Shield of Illinois

12

In an interview, Blue Cross and Blue Shield of Illinois medical
director Arnold Widen discussed the practice guidelines that
Blue Cross and Blue Shield is including in the contracts of some
specialists who are applying to join its new point-of-service
product,
Managed
Care
Network
Preferred
(MCNP).
Introduction of the practice guidelines in fall 1993 brought
swift objections from organized medicine, particularly the AMA
and the Illinois State Medical Society. Though Blue Cross and
Blue Shield plans to expand the guidelines, so far only 8 have
been set:
coronary artery bypass grafts, angioplasty,
laparoscopic gallbladder removals, new red blood cell
transfusions, breast-conserving lumpectomies, and 3 oncology
guidelines.

V.

STRENGTHS AND WEAKNESSES OF DISEASE MANAGEMENT

8

The diagnosis-specific approach can achieve high levels of validity
when the standards are developed and applied properly.
The
approach can also yield a continuous score for the quality of care
provided, ranging from superior to grossly substandard. This attribute
allows for the identification of marginally suboptimal care as well as
that which is frankly substandard. Some of the other approaches to
be discussed below tend to focus on a fairly narrow range of
substandard care and lack the sensitivity to detect the marginally
suboptimal.

11

The disadvantage of the diagnosis-specific approach is that it is
costly, both to develop the criteria and to apply them. Thus, the
diagnosis-specific approach tends to focus on a relatively small
number of diagnostic categories. Kessner et al, however, attempted
to illustrate how a limited set of diagnoses or "tracer conditions"
could serve as a adequate proxy for a much broader range of care
given by a provider.
If an investigator's goal is to liSe tracer
conditions to provide a broad assessment of the quality of a given
institution, facility, or even a health care system, the tracers must be
carefully chosen to provide the maximum coverage and impact. To
make a general assessment of a facility, the investigator may prefer
to select as tracers a sample of conditions which are relatively
common, for which there are well-established standards, and for
which failure to adhere to standards has fairly severe consequences.
A final feature of the diagnosis-specific approach which can be both
an advantage and a disadvantage is that it focuses primarily on
process. This focus has the advantage of allowing the investigator to
make more detailed judgments about quality that possible with other
methods to be described primarily because it allow and in-depth
examination of the treatment decisions made throughout an episode
of care. However, as with process measures in general, it is often
difficult to quantify the clinical impact of deviations from the
established standards. Almost all cases fail to meet at least one of
the standards. It is difficult, however, to tell in an absolute sense
how serious the failure is in terms of actual or potential harm to the
patient.
As a result of these considerations, the primary uses of the diagnosisspecific approach are for focused review (i.e., review which is
targeted on known or potential problem areas) and research. The
method may be particularly suited to ongoing use in a clinical setting
over time, for example, for use by a hospital's quality assurance
department or by a medical school in evaluating the effectiveness of
its clinical training programs.
The clinical specificity of the
information gleaned in the review makes the method particularly
applicable to the monitoring and correcting of individual practitioner
performance. It is not, however, a realistic approach for wide scale
monitoring.

12

VI.

DISEASE MANAGEMENT

A.

9

Key Capabilities

Managing the disease, not the components of cost, is among
the key capabilities now required.
Most care management
strategies are focused on managing the total cost of-each slice
of the health care pie, such as hospital days, doctors' visits,
pharmacy and diagnostics. Each episode of care becomes a
transaction: a cost unit to be managed. Price and utilization
control are the answers to all questions. In fact, this greatly
constrains the potential for managing the real unit of cost: the
disease. A disease management approach views an episode of
care as a point on the continuum of a patient with a specific
set of health care resource needs.
Instead of disregarding what the system knows about the
patient and the disease, the disease management approach
encourages doctors and care managers to anticipate the
management of the case. It enables physicians to make the
appropriate choices around the key junctures in the clinical
process that drive the quality and cost of care. Focusing the
medical management initiatives to achieve more consistent care
delivery at these critical junctures offers much greater potential
benefit than focusing the energy of the medical director's office
on eliminating the last day of hospital care. Key elements of
such a strategy are to assemble and record the knowledge
about what it costs to restore health at different stages of a
disease and how patient health outcomes correlate with
comprehensive treatment programs and to evaluate the costeffectiveness of various preventive measures.
For example, while a cost-component view of asthma might
dictate against early referrals to specialists or constrain
formulary choices for specific drugs, a disease management
approach would find that for severe asthmatics encouraging
early referrals to a pulmonary specialist, use of inhaled steroids
and/or an expensive new drug could generate significant
savings by avoiding costly emergency room visits later, while
also improving the patient's quality of life.
Some studies
suggest that a comprehensive disease management strategy for
asthma could save as much as 25 % of the total cost for
moderate to severe asthmatics.

13

More managed care organizations are adopting disease
management as the centerpiece of their strategies to cut cost
and improve quality. United Health Care, a national managed
care organization based in Minneapolis, is developing a portfolio
of programs ranging from its maternity care program to the
United Resource Network to facilitate the access of its
members to donor organs when needed. John Deere Health
Care is collaborating with the Mayo Clinic to develop a broad
set of disease-specific strategies to be implemented at both
institutions.
The disease range from heart disease to
depression.
As with any fundamental redesign of the value creation
process, the organizational requirements for coordinated
disease management are stringent.
Successful execution
requires intensive involvement by the members, employers,
physicians and
system
managers.
It also requires
unprecedented levels of cooperation with providers on
incentives, network design, information flow and behavioral
expectations. At a minimum, care managers must be highly
integrated with the network designers.
Collaborative product design is a second key capability.
Heightened competition in managed care will make it necessary
for companies to respond to consumer demand for specialized
services within standardized product offerings or benefit
coverage. Whether consumers buy their health care directly or
through large government or employer coalitions, there is a
opportunity to tailor services to their specific needs.
This
ensures that a product addresses a current market need and
allows for more effective sharing of a high cost investment or
underwriting health risk.
Health Partners, formerly known as Group Care, in Minneapolis,
for example, surveyed the employees of the 14 employers in
the Business Health Care Action Group coalition to assess their
health status and lifestyle habits. It then used this information
to develop its wellness programs and to identify the disease for
which it would create care management protocols. The health
system made sure it managed the specific diseases and
conditions it customers cared about most. It also helped them
avoid the costs of managing complexity by narrowing the range
of products it offered employers.

14

Partnership with providers is a third critical capability.
Networks of physicians and hospitals are beginning to compete
directly with managed care companies by building integrated
systems with the ability to assume risk, develop effective
managed care programs and process their own claims. To
keep providers out of the ranks of the competition, managed
care needs to find ways to work with them more effectively. A
vaguely antagonistic relationship now exists largely because of
mistrust and a lack of common understanding by the provider
groups and the managers of managed care systems. Providers
suspect that managers focus primarily on costs and sacrifice
quality of care by second-guessing the decisions of care givers,
who are closest to the patient.
Managers assume that
providers generally treat patients without regard to cost. Even
staff-model
HMOs
often
have
difficulty
getting
the
administrative/business and medical management hierarchies to
work effectively on care-management issues.
The challenge for managed care is to establish a mechanism
that encourages providers to deliver quality care while being
aware of the cost of the treatments they choose.
But
empowering physician decision-making raises concerns about
losing control. A solution is to ask the physicians themselves
to become partners with insurers or managed care
organizations in creating the guidelines and network platforms
for managing their panel of patients, while sharing the benefits
that accrue from giving the patient the best, most costeffective treatment. This can translate into new types of risksharing agreements supported by meaningful information on
physician performance. U.S. Healthcare recently modified its
physician compensation
programs to
reflect improved
performance measured in specific ways. An alternative is to
reduce the stress and day-to-day annoyance in office practice
and managed care. Several companies are exploring ways to
enhance the efficiency of the physician's back office through
better office management and connection with the local
administrative offices.
The final capability, an enabler more that a cross-functional
process, is providing integrated information management.
Health care delivery programs must make information
technology work for quality health care as well as it does for
efficient transaction processing.
Many managed care
companies originally focused their information technology
capability on building a financial control system - collecting
15

premiums and supporting the component management and
referral management strategy. Few companies have been able
to realize the enormous opportunities to increase member and
provider satisfaction, manage administrative and medical costs,
and support quality-of-care initiatives through effective
deployment of information technology. Unfortunately, several
companies, including a few Blue Cross and BIHe Shield
organizations, have almost broken the bank trying to get there.
At the heart of this key capability platform is the need to link
appropriate constituencies with the key database-adding
functionality to meet the needs of each user.
Within the
managed care organization, this includes making common
clinical and administrative data accessible to clinicians,
marketing, underwriting and network designers. At a minimum,
a medical system application might have a tickler file for
physicians, reminding them that certain patients must be called
in for follow-up care at appropriate times when additional
outcomes information and patient satisfaction data also can be
collected. This information could be used to create new care
management tools or refine existing ones.
A more visionary system might provide access to high-quality,
up-to-date medical data to help clinicians diagnose, treat and
follow up with patients more effectively. A doctor diagnosing a
patient, for instance, could call up an agreed-upon treatment
protocol on a clinical workstation and get the latest data on the
trade-offs among various medical, surgical
and
drug
interventions. He or she also might get information about the
outcomes associated with each treatment combination, in
terms of patient health status and satisfaction with the care
process.

B.

Disease Management Themes

1.

2.

4

Although there is not widespread use of disease
management techniques in the industry presently, the
systematic focus on specific diseases is intuitively sound,
is being conducted by several leading-edge healthcare
delivery systems, and is supported by specific cost
reduction and quality improvement evidence and study.
The focus on specific diseases is intuitively sound due to
specific study evidence which identifies that 5 % of
patients account for 70% of the costs associated with
16

certain diseases with the majority of costs associated
with out-of-control cases.
3.

Disease management approaches have largely been an
outgrowth of quality improvement efforts where
population-based
approaches
to
clinical
quality
improvement have led to focus on high volume health
problems and chronic conditions.

4.

The industry leaders as well as others that are involved
in disease management approaches are utilizing COi
approaches/models to conduct improvement efforts.

5.

Experts suggest that integrated delivery systems offer
the most viable model to conduct effective disease
management since these systems bring medical and cost
data together most efficiently. More open models require
a more intense investment in information systems, but
preserve greater choice among providers for patients.

6.

Disease management can be a basis for integration
inasmuch as the high volume disease problems of
populations/customers can dictate which
"disease
specific" network providers are required.

7.

The pharmaceutical industry through its Pharmacy
Benefit Management (PMBs) are in collaboration with
managed care organizations and managed care "specialty
services" organizations (Value Health, GMIS, etc.) on
disease management as an added value proposition.

8.

Disease management approaches may run counter to the
role of PCPs as most chronic cases may be best suited
for "specialty care networks".

9.

There are a variety of disease management models which
includes "disease carveouts" through capitation, casespecific nurse disease management, and triage to disease
specialist who becomes the disease PCP.

10.

Key capabilities in managed care start with managing the
disease, not the components of cost.
Price and
utilization control can constrain the potential for
managing the real unit of cost - the disease. The disease
management approach anticipates the management of
17

the case. As an example, some studies suggest that a
comprehensive disease management strategy for asthma
could save as much as 25 % of the total cost for
moderate to severe asthmatics. Care managers must be
highly integrated with the network designers.
Other
capabilities include:
collaborative product design;
partnerships with providers; and integrated ir+formation
management.

18

REFERENCES

1.

Weiss, et al., "An Economic Evaluation of Asthma in the United
States", The New England Journal of Medicine, March 26, 1992.

2.

Broshy, et al., "Want to curb health costs? Manage the disease, not
each cost component" Medical Marketing and Media, September
1993.

3.

Peterson, Carl, "Pharmacy Integration - Going Vertical", HMO
Magazine, Sept-Oct 1994.

4.

BCBSF, Health Care Services Summary on Quality of Care.

5.

Andrew W. Nighswander, "Integrated Health Care Delivery: A
Blueprint for Action". In interstudy Publications, Pathway series,
September 1994.

6.

Richard T. Loeffler, M.D., "Measuring Quality of Care In Physicians
Offices". In Ambulatory Care Manage, Aspen Publishers, 1992.

7.

John T. Kelly, M.D., PhD and James E. Swartwout, M.D., "Practice
Parameters: A foundation For Quality Advancement". In AAPO
Journal, February/March 1991.

8.

Christy Moynihan, "Quantifying Quality". In E.F.X. Hughes (Ed.),
Perspectives in Quality in American Health Care, (pp. 35-60), 1988,
Washington, DC: McGraw Hill

9.

Curtis Kemeny and Martin Silverstein, "Managed Care Under
Pressure". In Bests Review, UH, July 1994.

10.

Valentine Cardinale, "1994 Annual Meeting of the National Wholesale
Druggists Association".

11.

Cindy E. Cordero and Lynne Christensen, "Utilization Review". In
Business & Health, Vol. 10, lss: 9, August 1992.

1 2.

Jim Montague, "Managed Care; Standards; Medical Procedures.:
From an interview with Illinois Blue Cross and Blue Shield Medical
Director, Arnold Widen. In Hospital and Health Networks (HPT), Vol:
68, lss: 4, February 20, 1994.

